Skip to main content
. Author manuscript; available in PMC: 2024 Apr 9.
Published in final edited form as: Eur J Cancer. 2023 Mar 23;186:172–184. doi: 10.1016/j.ejca.2023.03.015

Fig. 1.

Fig. 1.

HRQoL Disposition. aIncludes clinical progression and progressive disease. European Organisation for Research and Treatment of Cancer; EN24, Endometrial, 24 questions; EQ-5D-5L, EuroQoL 5 dimensions, 5 levels; HRQoL, health-related quality of life; LEN, lenvatinib; PEMBRO, pembrolizumab; QLQ-C30, Quality-of-Life Questionnaire; TPC, treatment of physician’s choice.